Bizzell Develops Medscape Article on the Interactions Between Dementia, Diabetes and Cardiovascular Disease

Bizzell Develops Medscape Article on the Interactions Between Dementia, Diabetes and Cardiovascular Disease

The Bizzell Group (Bizzell) has recently developed an article, published on Medscape, which explores the interactions between dementia, diabetes, and cardiovascular disease.  The article, Bidirectional Impact of Alzheimer’s Disease and Common Comorbid Conditions, is available as an online CME activity and was developed under a contract with the U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) in collaboration with the HHS, Office of Women’s Health.

It is intended for primary care providers, neurologists, psychiatrists, geriatricians, and other health care team members and addresses the complexities of treating patients with Alzheimer’s disease and common coexisting conditions, specifically cardiovascular disease (CVD) and diabetes (T2D).

These comorbidities can impact the severity and progression of the disease and require individualized, patient-centered approaches and thoughtful medical reasoning. The module discusses common challenges and considerations in the identification, diagnosis, and treatment of patients with Alzheimer’s disease and T2D or CVD.  Useful diagnostic tools, guidelines, and patient resources are provided.

Bizzell CEO Contributes Chapter to The ASAM Principles of Addiction Medicine

Bizzell CEO Contributes Chapter to The ASAM Principles of Addiction Medicine

Anton Bizzell, M.D., CEO of The Bizzell Group (Bizzell) celebrates the publication of the fifth edition of The ASAM Principles of Addiction Medicine.  The publication is the go-to textbook in the specialty field of addiction medicine, with the fifth edition providing core knowledge by “blending scientific principles underlying addiction with the practical essential of clinical addiction medicine.” The chapter, Ethical Issues in Addiction Practice was co-authored by Dr. Bizzell, H. Westley Clark, MD, JD, MPH, CAS, FASAM and Anthony Campbell, RPh, DO.

Dr. Bizzell brings significant experience within the health care community having served as a medical officer for the Substance Abuse and Mental Health Services Administration (SAMHSA) and with the National Institute on Alcohol Abuse and Alcoholism (NIAAA).   The chapter itself, details core ethical principles, aspects of dealing with denial, establishing an ethical stance, and potential future developments that could stimulate unprecedented paradigm shifts that may influence health care decision-making that would impact the disenfranchisement underlying health disparities in addiction treatment.

“It’s always an honor to be asked to participate in developing a narrative for something I’ve always been very passionate about,” Dr. Bizzell said in a statement.  “Its one thing to manage programs and work with people addressing addictive behaviors nationwide, but to be able to contribute to the field, and educate others is equally as rewarding. “

The ASAM Principles of Addiction Medicine Fifth Edition may be ordered through the publisher Lippincott Williams & Wilkins and includes a fully searchable online app version of the text and appendices and review questions. Phone orders dial 1-800-638-3030.

Bizzell Supports HBCU Campus Dialogue on Prescription Drugs

Bizzell Supports HBCU Campus Dialogue on Prescription Drugs

The Bizzell Group (Bizzell) supports The National Council on Patient Information and Education (NCPIE) with its recruitment of students, staff, and faculty from Historically Black Colleges and Universities (HBCUs) for an open dialogue on prescription drugs. The event LET’S TALK ABOUT IT: Prescription Drug Use and Its Side Effects is funded by the Substance Abuse and Mental Health Services Administration (SAMHSA).

The groups will discuss current campus trends, explore beliefs about substance abuse and addiction, and discover on- and off-campus prevention, treatment and recovery services.  There will be two sessions – one for faculty and staff on Friday, March 28th and one for students on Saturday, March 29th.

Research suggests that there are varied motivations for prescription drug abuse among teens and college-aged students, including getting high, coping with pain or sleep problems and in some instances improving or enhancing cognition.  These behaviors are risky as medications prescribed by doctors are assumed to be safe, however abuse of these drugs can have harmful health effects, including overdose.  This discussion seeks to open a dialogue among students and health professionals to combat myths and generalizations about prescription drug misuse.

Faculty and staff are encouraged to RSVP by March 21, 2014 for the event on March 28th from 10 am – 3 pm.  Students should RSVP by March 25, 2014 for the event on March 29th from 11 am – 4 pm. Interested participants should RSVP by calling 202.806.7706 or emailing dm_barnes@howard.edu.

Both sessions will take place at The Gallery Lounge in the Blackburn Center at Howard University, 2400 Sixth Street, NW, Washington, DC 20059. Participants are advised that this counts as a community service activity and resume-builder.  Limited seating is available. Lunch and parking will be provided.

To learn more about the issue, visit: Taking Action to Prevent & Address Prescription Drug Abuse:  A Resource Kit for America’s College Campuses and www.recoveryopensdoors.org